Raleigh Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-71
| Closed | -$10.9K | – | 625 |
|
|
2024
Q4 | $10.9K | Buy |
71
+17
| +31% | +$2.6K | ﹤0.01% | 599 |
|
|
2024
Q3 | $10.5K | Sell |
54
-41
| -43% | -$7.95K | ﹤0.01% | 583 |
|
|
2024
Q2 | $22K | Buy |
95
+47
| +98% | +$10.9K | 0.01% | 417 |
|
|
2024
Q1 | $10.4K | Buy |
48
+18
| +60% | +$3.88K | ﹤0.01% | 558 |
|
|
2023
Q4 | $7.76K | Buy |
30
+5
| +20% | +$1.29K | ﹤0.01% | 653 |
|
|
2023
Q3 | $6.43K | Hold |
25
| – | – | ﹤0.01% | 638 |
|
|
2023
Q2 | $7.12K | Buy |
+25
| New | +$7.12K | ﹤0.01% | 556 |
|